( NASDAQ-SMALL:NTEC )

News from Intec Pharma Ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 15, 2018, 07:00 ET Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC) ("Intec" or "the Company") today announces financial results for the three months ended March 31,...


Apr 24, 2018, 07:00 ET Intec Pharma Presented Phase 1 PK and Safety Data From Accordion Pill Carbidopa/Levodopa at American Academy of Neurology Annual Meeting

Intec Pharma LTD (NASDAQ, TASE: NTEC) ("Intec" or "the Company") today announces that data collected from two Phase 1 studies of its proprietary...


Apr 13, 2018, 16:01 ET Intec Pharma Announces Closing of $35.4 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the closing of its previously announced offering of 6.75 million of its ordinary shares,...


Apr 11, 2018, 09:00 ET Intec Pharma Announces Pricing of $35.4 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the pricing of an underwritten public offering of 6.75 million of its ordinary shares at...


Apr 10, 2018, 16:01 ET Intec Pharma Announces Proposed Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC) today announced the launch of an underwritten public offering of its ordinary shares. In connection...


Apr 04, 2018, 08:00 ET Intec Pharma Announces Poster Presentation at American Academy of Neurology Annual Meeting

Intec Pharma LTD (NASDAQ: NTEC) (TASE: NTEC) ("Intec" or "the Company") today announces that data collected from the Company's Phase 2 development...


Apr 03, 2018, 08:00 ET Intec Pharma Ltd. to Host Key Opinion Leader Luncheon on Novel Drug Delivery Solutions in the Treatment of Parkinson's Disease

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based on...


Mar 26, 2018, 07:00 ET Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors

Intec Pharma LTD (NASDAQ, TASE: NTEC) ("Intec" or "the Company") today announces the appointment of Roger J. Pomerantz, M.D., F.A.C.P. to its...


Mar 12, 2018, 16:30 ET Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson's Disease

Intec Pharma Ltd. (NASDAQ, TASE: NTEC) ("Intec" or the "Company") today announces that it has partnered with LTS Lohmann Therapie-Systeme AG...


Mar 09, 2018, 07:00 ET Intec Pharma Reports Fourth Quarter and Year End 2017 Financial Results and Business Update

Intec Pharma LTD (NASDAQ: NTEC) (TASE: NTEC) today announces financial results for the three and twelve months ended December 31, 2017 and provides...


Mar 05, 2018, 07:15 ET Intec Pharma, Ltd. to Present at Four Investor Conferences in March

Intec Pharma Ltd. (NASDAQ: NTEC), a clinical-stage biopharmaceutical company focused on developing pharmaceutical therapies based on its...


Jan 31, 2018, 08:00 ET Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developing pharmaceutical therapies...


Jan 08, 2018, 08:00 ET Intec Pharma Announces Development Collaboration With Global Pharmaceutical Company

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary...


Jan 03, 2018, 08:00 ET Intec Pharma Granted Patent in Canada for Accordion Pill™ Carbidopa / Levodopa

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary...


Nov 15, 2017, 16:01 ET Intec Pharma Reports Third Quarter 2017 Operating and Financial Results

Intec Pharma LTD (NASDAQ: NTEC) (TASE: NTEC) today announced its third quarter 2017 financial results and provided a corporate update. "The third...


Nov 08, 2017, 08:00 ET Intec Pharma, Ltd. to Present at the Jefferies 2017 London Healthcare Conference

Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Nov 01, 2017, 07:00 ET Intec Pharma, Ltd. Announces Changes to its Board of Directors

Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Nov 01, 2017, 07:00 ET Intec Pharma Ltd. Announces Changes to its Board of Directors

Intec Pharma Ltd. (Nasdaq, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Oct 26, 2017, 07:00 ET Intec Pharma Names Walt Linscott as Chief Administrative Officer

Intec Pharma Ltd. (Nasdaq: NTEC) (TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary...


Oct 06, 2017, 07:00 ET Intec Pharma to Participate in the Oppenheimer Specialty Pharma Summit

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in the Oppenheimer Specialty Pharma Summit to be held...


Sep 20, 2017, 07:00 ET Intec Pharma to Participate in the Ladenburg Thalmann 2017 Healthcare Conference

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in the Ladenburg Thalmann 2017 Healthcare Conference to...


Sep 08, 2017, 10:38 ET Intec Pharma to Participate in the 19th Annual Rodman & Renshaw Global Investment Conference

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in the 19th Annual Rodman & Renshaw Global...


Sep 01, 2017, 08:00 ET Intec Pharma to Participate in BioCentury's 24th Annual NewsMakers in the Biotech Industry Conference

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced that management will participate in BioCentury's 24th Annual NewsMakers in the Biotech...


Aug 21, 2017, 16:15 ET Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the closing of its previously announced offering of approximately 12.2 million of its...


Aug 16, 2017, 09:00 ET Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the pricing of an underwritten public offering of approximately 10.6 million of its...